International Biotech Trust

(IBT)
Sector: Closed End Investments
698.00p
12.00p 1.75
Last updated: 12:05:09

Director dealings

Trade date Director Volume / Price Trade value Trade type
24/07/2024 Gillian Elcock 1,407 @ 708.58p £9,969.72 Buy
07/11/2023 Caroline Gulliver 2,500 @ 573.15p £14,328.75 Buy
03/08/2023 Patrick Magee 1,500 @ 632.00p £9,480.00 Buy
03/08/2023 Katherine Cornish-Bowden 1,500 @ 633.18p £9,497.70 Buy
11/05/2022 Patrick Maxwell 3,725 @ 589.35p £21,953.29 Buy
01/04/2022 Patrick Magee 2,500 @ 633.00p £15,825.00 Buy
21/03/2022 Katherine Cornish-Bowden 1,500 @ 644.00p £9,660.00 Buy
12/01/2022 Katherine Cornish-Bowden 1,500 @ 684.49p £10,267.35 Buy
02/11/2021 Patrick Magee 4,000 @ 735.00p £29,400.00 Buy
02/11/2021 Patrick Magee 4,000 @ 735.00p £29,400.00 Buy
02/11/2021 Patrick Magee 4,000 @ 735.00p £29,400.00 Buy
05/08/2021 Caroline Gulliver 2,000 @ 723.90p £14,478.00 Buy

Director shareholdings

Name Holding Percent
Caroline Gulliver 17,000 0.00%
Katherine Cornish-Bowden 12,500 0.00%
Patrick Magee 11,500 0.00%
Patrick Maxwell 3,725 0.00%
Gillian Elcock 1,407 0.00%

Major shareholders

Institution name Holding Percent
Hargreaves Lansdown Asset Management 5,226,816 13.29%
Border to Coast Pensions Partnership Limited 2,535,000 6.45%
Charles Stanley Group Plc 1,871,013 4.99%
A J Bell Securities 1,719,573 4.37%
M & G Investment Management 1,526,150 3.69%
Schroder Investment Management Ltd 1,454,736 3.88%
Brewin Dolphin 1,320,973 3.36%
West Yorkshire Pension Fund 1,245,599 3.17%